Loading insider details...
Beta
Latest Form 4 (May 30, 2025): Grant/Award of 55,000 FATE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 30, 2025 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 55,000 | n/a |
| Jun 21, 2024 | Omega Therapeutics, Inc. (OMGA) | Grant/Award | 25,000 | n/a |
| Jun 11, 2024 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 40,000 | n/a |
| Jun 7, 2023 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 40,000 | n/a |
| Jan 20, 2023 | FATE THERAPEUTICS INC (FATE) | Exercise/Conversion | 28,461 | $39.0K |
| Jan 13, 2023 | FATE THERAPEUTICS INC (FATE) | Purchase | 88,048 | $499.2K |
| Jun 13, 2022 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 8,650 | n/a |
| Jun 6, 2022 | FATE THERAPEUTICS INC (FATE) | Sale | 1,364 | $31.1K |
| Mar 11, 2022 | FATE THERAPEUTICS INC (FATE) | Exercise/Conversion | 31,562 | $51.4K |
| Jun 4, 2021 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 2,681 | n/a |